Results 221 to 222 of about 17,275 (222)

Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial

Lancet, The
John O Konz, Alan Fix
exaly  

CLINICAL EFFICACY OF A NEW, ENHANCED-POTENCY, INACTIVATED POLIOVIRUS VACCINE

Lancet, The, 1988
exaly